-  News

Albion invests in RegGenome

We are pleased to announce our investment in Regulatory Genome Development Ltd (RegGenome), a commercial spin-out from the University of Cambridge.

RegGenome has completed a £4.6 million seed funding round led by Evolution Equity Partners, with participation from us at Albion, Cambridge Enterprise and Mastercard.

RegGenome’s vision is to transform the way the world consumes regulatory information. The company’s structured machine-readable regulatory content service allows regulatory authorities to increase accessibility and dissemination of regulatory information and empowers organisations to deepen their regulatory and risk management processes.

Management Practice Professor Robert Wardrop, Executive Chairman of RegGenome, said:

We are thrilled to be working with a group of investors that share our view that the world is rapidly entering into a period of regulatory uncertainty, requiring interoperable content to power the next generation of regulatory applications for the digital economy.

Jay Wilson, Investment Director at Albion added:

Rapid technological, political and regulatory change continue to drive a lack of standardisation and data fragmentation within financial services, creating an opportunity for a paradigm shift in how regulatory content is delivered and consumed.  We are delighted to support Professor Robert Wardrop and his team which seek to accelerate the development of a transformative regulatory data service.

Related News